Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
10592studies shown
Showing 2,617-2,628 of 10,592
Drug study icon
CompletedNCT01940159

Safety study of SEP-363856 in schizophrenia

This study is completed in the United States. It is testing SEP-363856 for schizophrenia.

In United States
SchizophreniaDrugA study involving a medication or substance.From 18 Years to 50 Years
Countries
United States
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
Schizophrenia
Drug study icon
CompletedNCT00634348

Ziprasidone and Aripiprazole for schizophrenia

This study is completed in the United States. It is testing ziprasidone and Aripiprazole for schizophrenia.

In United States
SchizophreniaDrugFrom 18 Years to 70 Years
Countries
United States
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Condition
Schizophrenia
Other study type icon
CompletedNCT02947308

A Study Examining Adolescents With Non-Suicidal Suicide prevention

This study exists to see whether questionnaires and follow-up reports can make care clearer and more responsive. Researchers are trying to understand whether questionnaires and follow-up reports can improve attention, thinking, or day-to-day functioning.

In United States
SuicidalityOtherFrom 12 Years to 16 Years
Countries
United States
Sponsor
University of Minnesota
Condition
Suicidality
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.